@article {1040,
	title = {Lack of reduction in buprenorphine injection after introduction of co-formulated buprenorphine/naloxone to the Malaysian market.},
	journal = {The American journal of drug and alcohol abuse},
	volume = {35},
	year = {2009},
	month = {2009},
	pages = {68-72},
	abstract = {Diversion of buprenorphine (BPN) has been described in settings where it is legally prescribed and has resulted in increasing concern. To address this concern, co-formulation of buprenorphine/naloxone (BPN/NLX) replaced buprenorphine alone in Malaysia in December 2006.},
	keywords = {Adult, Buprenorphine, Drug Combinations, Humans, Logistic Models, Malaysia, Male, Middle Aged, Naloxone, Narcotic Antagonists, Needle Sharing, Opioid-Related Disorders, Risk-Taking, Substance Abuse, Intravenous, Substance Withdrawal Syndrome, Young Adult},
	issn = {1097-9891},
	doi = {10.1080/00952990802585406},
	author = {Bruce, R Douglas and Govindasamy, Sumathi and Sylla, Laurie and Kamarulzaman, Adeeba and Altice, Frederick L}
}
